Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-03-19 00:00:00 ET · period of report 2026-03-17 · accession 0001827672-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-19 | 2026-03-17+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $68.34 | -34.6K | 57.1K | -38% | -$2.36M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-19 | S | D | 11,964 | $67.00 | 33,421 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-18 | S | D | 11,667 | $68.71 | 45,385 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-17 | S | D | 10,972 | $69.42 | 57,052 | D | — | — |